Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease (MNEMOSYNE)

PHASE4CompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

January 31, 2011

Conditions
Early Onset Alzheimer Disease
Interventions
DIETARY_SUPPLEMENT

Neptune Krill Oil

Softgels 1g QD. Each softgel of Neptune Krill Oil will provide approximately 150 mg EPA and 100 mg DHA.

DIETARY_SUPPLEMENT

Fish Oil

Softgels 1g QD. Each softgel of Fish Oil will provide approximately 150 mg EPA and 100 mg DHA.

DIETARY_SUPPLEMENT

Placebo (soy oil)

Softgels 1g QD. The soy oil placebo will provide neither EPA nor DHA.

Trial Locations (14)

Unknown

Surrey

Deer Lake

St. John's

Cornwall

Hamilton

Hawkesbury

Newmarket

Ottawa

Sarnia

Thornhill

Thunder Bay

Dollard-des-Ormeaux

Grand-Mère

Montreal

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Neptune Technologies and Bioressources Inc.

INDUSTRY

lead

NeuroBioPharm Inc.

INDUSTRY